Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

NCT01947998 · clinicaltrials.gov ↗

COMPLETED

Status

50299

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thrombosis
Pulmonary Embolism
Atrial Fibrillation
Acute Coronary Syndrome

Interventions

DRUG: Rivaroxaban (Xarelto, Bay59-7939)
DRUG: Warfarin
DRUG: Antiplatelet drugs

Sponsor

Bayer

Collaborators

[object Object]